Publications de Matteo Gasbarri

Supramolecular Architectures of Dendritic Polymers Provide Irreversible Inhibitor to Block Viral Infection (Adv. Mater. 3/2025)

Francesco Stellacci, Matteo Gasbarri, Heyun Wang

Wiley2025

Benzene with Alkyl Chains Is a Universal Scaffold for Multivalent Virucidal Antivirals

Francesco Stellacci, Paulo Henrique Jacob Silva, Lixia Wei, Matteo Gasbarri, Yong Zhu, Heyun Wang

Most viruses start their invasion by binding to glycoproteins' moieties on the cell surface (heparan sulfate proteoglycans [HSPG] or sialic acid [SA]). Antivirals mimicking these moieties multivalently are known as broad-spectrum multivalent entry inhibito ...

Amer Chemical Soc2024

Supramolecular Architectures of Dendritic Polymers Provide Irreversible Inhibitor to Block Viral Infection

Francesco Stellacci, Matteo Gasbarri, Heyun Wang

In Nature, most known objects can perform their functions only when in supramolecular self-assembled from, e.g. protein complexes and cell membranes. Here, a dendritic polymer is presented that inhibits severe acute respiratory syndrome coronavirus 2 (SARS ...

Wiley2024

Broad-Spectrum Supramolecularly Reloadable Antimicrobial Coatings

Francesco Stellacci, Matteo Gasbarri, Lukasz Richter, Francesca Olgiati, Heyun Wang

Antimicrobial surfaces limit the spread of infectious diseases. To date, there is no antimicrobial coating that has widespread use because of short-lived and limited spectrum efficacy, poor resistance to organic material, and/or cost. Here, we present a pa ...

Amer Chemical Soc2024

Development of an inhalable antiviral powder formulation against respiratory syncytial virus

Daniel Ortiz Trujillo, Francesco Stellacci, Paulo Henrique Jacob Silva, Matteo Gasbarri

Respiratory viruses including the respiratory syncytial virus (RSV) aggravate the global burden of virus-inflicted morbidity and mortality. Entry inhibitors are a promising class of antiviral drugs for combating these viruses, as they can prevent infection ...

ELSEVIER2023

Antiviral compounds, compositions and uses thereof

Francesco Stellacci, Matteo Gasbarri, Yong Zhu

Compounds, compositions and methods that can be used for the treatment of viral diseases are provided. ...

2023

Potent Virustatic Polymer-Lipid Nanomimics Block Viral Entry and Inhibit Malaria Parasites In Vivo

Francesco Stellacci, Matteo Gasbarri

Infectious diseases continue to pose a substantial burden on global populations, requiring innovative broad-spectrum prophylactic and treatment alternatives. Here, we have designed modular synthetic polymer nanopartides that mimic functional components of ...

AMER CHEMICAL SOC2022

Polyanionic Amphiphilic Dendritic Polyglycerols as Broad-Spectrum Viral Inhibitors with a Virucidal Mechanism

Francesco Stellacci, Valeria Cagno, Matteo Gasbarri

Heparin has been known to be a broad-spectrum inhibitor of viral infection for almost 70 years, and it has been used as a medication for almost 90 years due to its anticoagulant effect. This nontoxic biocompatible polymer efficiently binds to many types of ...

American Chemical Society2022

Sulfated and sulfonated dendritic polyglycerols and use thereof as broad-spectrum virucidal agents

Francesco Stellacci, Matteo Gasbarri

The invention relates to dendritic polyglycerol (dPG) compounds with alkyl-sulfonate/ sulfate functional groups that irreversibly inhibit viral infection (virucidal effect) through multivalent interaction in nanomolar concentration range. While the compoun ...

2022

Novel broad-spectrum virucidal antivirals

Matteo Gasbarri

The current COVID-19 pandemic has showed the threats that viruses can cause to the whole world. Over 200 million infections and over 4.5 million deaths and enormous socio-economic impact were the output of the emergence of a single new pathogen: SARS-CoV-2 ...

EPFL2021

Advances in the development of entry inhibitors for sialic-acid-targeting viruses

Francesco Stellacci, Özgün Kocabiyik, Matteo Gasbarri

Over the past decades, several antiviral drugs have been developed to treat a range of infections. Yet the number of treatable viral infections is still limited, and resistance to current drug regimens is an ever-growing problem. Therefore, additional stra ...

ELSEVIER SCI LTD2021

Broad-spectrum nanoparticles against bacteriophage infections

Francesco Stellacci, Paulo Henrique Jacob Silva, Zekiye Pelin Güven, Urszula Beata Cendrowska, Matteo Gasbarri, Lukasz Richter, Francesca Olgiati

Viral infections caused by bacteriophages, i.e., viruses that kill bacteria are one of the most dangerous and common threats for bacteria-based bioreactors. More than 70% of biotechnology companies have admitted to encountering this problem. Despite phage ...

ROYAL SOC CHEMISTRY2021

An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles

Francesco Stellacci, Matteo Gasbarri

Minimizing the spread of viruses in the environment is the first defence line when fighting outbreaks and pandemics, but the current COVID-19 pandemic demonstrates how difficult this is on a global scale, particularly in a sustainable and environmentally f ...

Nature Research2021

Cholesterol Hinders the Passive Uptake of Amphiphilic Nanoparticles into Fluid Lipid Membranes

Francesco Stellacci, Matteo Gasbarri, Ester Canepa, Giulia Rossi

Plasma membranes represent pharmacokinetic barriers for the passive transport of site-specific drugs within cells. When engineered nanoparticles (NPs) are considered as transmembrane drug carriers, the plasma membrane composition can affect passive NP inte ...

AMER CHEMICAL SOC2021

Sulfonated Nanomaterials with Broad-Spectrum Antiviral Activity Extending beyond Heparan Sulfate-Dependent Viruses

Francesco Stellacci, Valeria Cagno, Matteo Gasbarri, Chiara Medaglia

Viral infections are among the main causes of death worldwide, and we lack antivirals for the majority of viruses. Heparin-like sulfated or sulfonated compounds have been known for decades for their ability to prevent infection by heparan sulfate proteogly ...

AMER SOC MICROBIOLOGY2020

SARS-CoV-2 Inhibition by Sulfonated Compounds

Francesco Stellacci, Valeria Cagno, Matteo Gasbarri

Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) depends on angiotensin converting enzyme 2 (ACE2) for cellular entry, but it might also rely on attachment receptors such as heparan sulfates. Several groups have recently demonstrated an ...

2020

Modified cyclodextrins as broad-spectrum antivirals

Daniel Ortiz Trujillo, Francesco Stellacci, Natalia Gasilova, Samuel Thomas Jones, Matej Janecek, Valeria Cagno, Matteo Gasbarri

Viral infections kill millions of people and new antivirals are needed. Nontoxic drugs that irreversibly inhibit viruses (virucidal) are postulated to be ideal. Unfortunately, all virucidal molecules described to date are cytotoxic. We recently developed n ...

AMER ASSOC ADVANCEMENT SCIENCE2020

Synthesis and Characterization of Amphiphilic Gold Nanoparticles

Francesco Stellacci, Paulo Henrique Jacob Silva, Zekiye Pelin Güven, Zhi Luo, Samuel Thomas Jones, Urszula Beata Cendrowska, Matteo Gasbarri

Gold nanoparticles covered with a mixture of 1-octanethiol (OT) and 11-mercapto-1-undecane sulfonic acid (MUS) have been extensively studied because of their interactions with cell membranes, lipid bilayers, and viruses. The hydrophilic ligands make these ...

JOURNAL OF VISUALIZED EXPERIMENTS2019